| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 395.408.657 $ | 99,96 | 2.149.423 | ||||||
| Amgen Inc | Amgen Inc | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 60.317.604 $ | 15,25 | 166.568 | |
| Gilead Sciences Inc | Gilead Sciences Inc | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 50.578.703 $ | 12,79 | 400.338 | |
| Vertex Pharmaceuticals Inc | Vertex Pharmaceuticals Inc | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 36.005.474 $ | 9,10 | 72.485 | |
| Regeneron Pharmaceuticals Inc | Regeneron Pharmaceuticals Inc | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 24.559.994 $ | 6,21 | 39.388 | |
| Revolution Medicines Inc | Revolution Medicines Inc | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 20.859.434 $ | 5,27 | 111.381 | |
| Argenx SE | Argenx SE | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 19.666.868 $ | 4,97 | 21.198 | |
| Natera Inc | Natera Inc | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 19.456.722 $ | 4,92 | 71.677 | |
| IQVIA Holdings Inc | IQVIA Holdings Inc | EC | 46266C105 | Long | Börsenkurs (Stufe 1) | 17.034.275 $ | 4,31 | 88.160 | |
| Alnylam Pharmaceuticals Inc | Alnylam Pharmaceuticals Inc | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 15.159.269 $ | 3,83 | 50.358 | |
| Biogen Inc | Biogen Inc | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 14.345.088 $ | 3,63 | 66.394 | |
| Moderna Inc | Moderna Inc | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 13.302.269 $ | 3,36 | 189.951 | |
| Illumina Inc | Illumina Inc | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 12.542.657 $ | 3,17 | 71.334 | |
| United Therapeutics Corp | United Therapeutics Corp | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 11.176.869 $ | 2,83 | 20.628 | |
| BeOne Medicines Ltd | BeOne Medicines Ltd | EC | 07725L102 | Long | Börsenkurs (Stufe 1) | 11.112.690 $ | 2,81 | 38.996 | |
| Insmed Inc | Insmed Inc | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 10.560.498 $ | 2,67 | 99.048 | |
| Incyte Corp | Incyte Corp | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 9.856.199 $ | 2,49 | 86.946 | |
| Neurocrine Biosciences Inc | Neurocrine Biosciences Inc | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 8.235.463 $ | 2,08 | 48.865 | |
| BioNTech SE | BioNTech SE | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 7.680.533 $ | 1,94 | 82.542 | |
| ICON PLC | ICON PLC | EC | IE0005711209 | Long | Börsenkurs (Stufe 1) | 7.524.943 $ | 1,90 | 43.319 | |
| Bio-Techne Corp | Bio-Techne Corp | EC | 09073M104 | Long | Börsenkurs (Stufe 1) | 6.097.802 $ | 1,54 | 86.310 | |
| Charles River Laboratories International Inc | Charles River Laboratories International Inc | EC | 159864107 | Long | Börsenkurs (Stufe 1) | 5.942.578 $ | 1,50 | 26.203 | |
| BioMarin Pharmaceutical Inc | BioMarin Pharmaceutical Inc | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 5.294.567 $ | 1,34 | 92.530 | |
| QIAGEN NV | QIAGEN NV | EC | NL0015002SN0 | Long | Börsenkurs (Stufe 1) | 4.211.578 $ | 1,06 | 107.713 | |
| Tempus AI Inc | Tempus AI Inc | EC | 88023B103 | Long | Börsenkurs (Stufe 1) | 3.886.582 $ | 0,98 | 67.091 | |
| Gesamt | 395.408.657 $ | 99,96 | 2.149.423 |